|
ATF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.88939999493599E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.799200E-03 |
| Normal-vs-Stage2 |
5.738000E-03 |
| Normal-vs-Stage3 |
5.6190000430334E-09 |
| Normal-vs-Stage4 |
4.65010000505472E-08 |
| Stage1-vs-Stage2 |
3.398800E-01 |
| Stage1-vs-Stage3 |
3.601800E-04 |
| Stage1-vs-Stage4 |
3.597900E-04 |
| Stage2-vs-Stage3 |
1.128810E-01 |
| Stage2-vs-Stage4 |
7.052200E-02 |
| Stage3-vs-Stage4 |
6.569800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41710000020912E-07 |
| Normal-vs-AfricanAmerican |
1.95100000044413E-07 |
| Normal-vs-Asian |
7.118200E-01 |
| Caucasian-vs-AfricanAmerican |
1.522190E-02 |
| Caucasian-vs-Asian |
1.066800E-01 |
| AfricanAmerican-vs-Asian |
1.153740E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86959997378256E-09 |
| Normal-vs-Female |
2.125000E-03 |
| Male-vs-Female |
2.394000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.723100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.558270E-04 |
| Normal-vs-Age(61-80Yrs) |
1.33909999977533E-07 |
| Normal-vs-Age(81-100Yrs) |
4.177700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.886380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.543800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.204000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.627980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.682960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.973000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.071400E-01 |
| Normal-vs-Grade 2 |
1.437090E-03 |
| Normal-vs-Grade 3 |
3.7330000002278E-07 |
| Normal-vs-Grade 4 |
4.8195003543583E-11 |
| Grade 1-vs-Grade 2 |
1.330020E-01 |
| Grade 1-vs-Grade 3 |
3.306100E-02 |
| Grade 1-vs-Grade 4 |
3.365200E-04 |
| Grade 2-vs-Grade 3 |
3.487700E-02 |
| Grade 2-vs-Grade 4 |
1.61698999999738E-05 |
| Grade 3-vs-Grade 4 |
7.836300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.592580E-01 |
| Normal-vs-ccB subtype |
3.34959999737094E-08 |
| ccA subtype-vs-ccB subtype |
1.74410999999042E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.50290000000752E-05 |
| Normal-vs-N1 |
6.565700E-02 |
| N0-vs-N1 |
3.982800E-01 |
|
|
